Kendall Capital Management’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.99M Buy
8,136
+672
+9% +$157K 0.41% 61
2025
Q4
$1.54M Sell
7,464
-51
-0.7% -$10.1K 0.32% 78
2025
Q3
$1.39M Sell
7,515
-25
-0.3% -$4.28K 0.31% 74
2025
Q2
$1.15M Sell
7,540
-43
-0.6% -$6.61K 0.3% 88
2025
Q1
$1.26M Sell
7,583
-53
-0.7% -$8.29K 0.37% 72
2024
Q4
$1.1M Buy
7,636
+83
+1% +$12.9K 0.32% 82
2024
Q3
$1.22M Buy
7,553
+10
+0.1% +$1.59K 0.38% 78
2024
Q2
$1.1M Buy
7,543
+365
+5% +$54.3K 0.37% 79
2024
Q1
$1.14M Hold
7,178
0.39% 81
2023
Q4
$1.13M Buy
7,178
+187
+3% +$28.7K 0.44% 74
2023
Q3
$1.09M Sell
6,991
-113
-2% -$18.6K 0.48% 65
2023
Q2
$1.18M Sell
7,104
-162
-2% -$26.1K 0.52% 65
2023
Q1
$1.13M Sell
7,266
-35
-0.5% -$5.65K 0.54% 59
2022
Q4
$1.29M Sell
7,301
-219
-3% -$37.8K 0.65% 46
2022
Q3
$1.23M Sell
7,520
-39
-0.5% -$6.6K 0.72% 44
2022
Q2
$1.34M Sell
7,559
-144
-2% -$25.7K 0.74% 42
2022
Q1
$1.36M Sell
7,703
-220
-3% -$37.4K 0.66% 44
2021
Q4
$1.35M Buy
7,923
+488
+7% +$79.9K 0.64% 49
2021
Q3
$1.2M Buy
7,435
+682
+10% +$116K 0.65% 54
2021
Q2
$1.11M Sell
6,753
-49
-0.7% -$8.11K 0.63% 53
2021
Q1
$1.12M Buy
6,802
+170
+3% +$27.5K 0.69% 48
2020
Q4
$1.04M Buy
6,632
+328
+5% +$48.4K 0.76% 45
2020
Q3
$939K Buy
6,304
+713
+13% +$106K 0.82% 44
2020
Q2
$786K Buy
5,591
+821
+17% +$120K 0.75% 51
2020
Q1
$625K Buy
4,770
+276
+6% +$39.2K 0.71% 52
2019
Q4
$656K Buy
4,494
+274
+6% +$37.2K 0.52% 65
2019
Q3
$546K Buy
4,220
+100
+2% +$13.2K 0.48% 71
2019
Q2
$574K Buy
4,120
+375
+10% +$51.9K 0.52% 67
2019
Q1
$524K Buy
3,745
+775
+26% +$104K 0.5% 64
2018
Q4
$383K Sell
2,970
-363
-11% -$50.6K 0.4% 73
2018
Q3
$461K Buy
3,333
+309
+10% +$41.1K 0.39% 73
2018
Q2
$367K Sell
3,024
-25
-0.8% -$3.12K 0.32% 83
2018
Q1
$391K Buy
3,049
+625
+26% +$84.5K 0.34% 78
2017
Q4
$339K Buy
+2,424
New +$338K 0.3% 84

Other funds holding JNJ

Kendall Capital Management's JNJ Position: Q1 2026 in Review

Kendall Capital Management increased its Johnson & Johnson (JNJ) stake by 9% in Q1 2026, buying an estimated $157K and bringing the position to 8,136 shares worth $1.99M. The position accounts for 0.41% of the portfolio, ranked #61.

Kendall Capital Management first reported a position in JNJ in Q4 2017 and has held it in 34 quarters since. 4,614 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • Kendall Capital Management held 8,136 shares of Johnson & Johnson worth $1.99M as of Q1 2026.
  • Kendall Capital Management bought 672 Johnson & Johnson shares in Q1 2026, an estimated $157K.
  • Johnson & Johnson made up 0.41% of Kendall Capital Management's portfolio in Q1 2026, its #61 holding.
  • Kendall Capital Management first reported a position in Johnson & Johnson in Q4 2017 and has held it in 34 quarters since.
  • 4,614 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Kendall Capital Management's 13F filing for Q1 2026, filed 24 Apr 2026.